A Study of AMDX-2011P in Participants With Alzheimer's Disease
Status:
RECRUITING
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer's Disease (AD).